TOS’s poster sessions run all the hours that the exhibit hall is open, but the only time you can meet and talk to the presenters about their research is during the lunchtime poster sessions. Please note that each poster is displayed for one day only, so check back daily for more cutting-edge research! Full abstracts will be available on the website, in printed abstract book and in the app once the embargo lifts on Tuesday, Nov. 13 at 12:00 a.m. ET (midnight).


12:00pm T-P-3422 A Clinical Experience: Low-dose Topiramate in Obesity Treatment in a Minneapolis VA Population
Authors: Darin Ruanpeng, MD; Amy A Gravely; Charles J Billington, MD; Shalamar D Sibley, MD
Presenter: Darin Ruanpeng, MD
12:00pm T-P-3423 Pharmacotherapy Use in Pediatric Weight Management Programs in U.S.
Authors: Claudia K Fox, MD MPH; Eileen King, PhD; Seema Kumar, MD; Jennifer K Yee, MD; Jared M Tucker, PhD; Brooke Sweeney, MD; Suzanne E Cuda, MD; Claudia Borzutzky, MD; Jon Oden; Shelley Kirk, PhD RD
Presenter: Claudia K Fox, MD MPH
12:00pm T-P-3424 Positive Effects of GLP-1 Receptor Agonist Treatment in a Prader-Willi Syndrome Case Study
Authors: Ashley K Mudra, PA-C; Gauri Dhir, MD; William T Donahoo, MD; Diana Barb, MD FTOS
Presenter: Diana Barb, MD FTOS
12:00pm T-P-3425 Weight Loss Clinical Outcomes to Obesity Pharmacotherapy: ‘Real-world’ Experience at the Mayo Clinic
Authors: Gerardo Calderon, MD; Oscar Garcia, MD; Maria Collazo-Clavell, MD; Meera Shah, MD; Daniel L Hurley, MD; Haitham Abu Lebdeh, MD MSc; Kristine Schmitz, RDN; Karen Grothe, PhD; Barham K Abu Dayyeh, MD MPH FASGE; Matthew Clark, PhD; Michael Camilleri, MD; Manpreet Mundi, MD; Andres Acosta, MD PhD
Presenter: Andres Acosta, MD PhD
12:00pm T-P-3426 Efficacy and Safety of Ertugliflozin in Patients With Type 2 Diabetes and BMI ≥25 kg/m²
Authors: Steven B Heymsfield, MD FTOS; Silvina Gallo; Jay Liu; Annpey Pong, PhD; Annaswamy Raji, MD MMSc FACE; Hakima Hannachi
Presenter: Steven B Heymsfield, MD FTOS
12:00pm T-P-3427 Association of Diurnal Glycemic Variability and Glycemic Medication in Adults With Type 2 Diabetes
Authors: Pennie J Taylor, PhD(c); Kylie Lange, BSc; Campbell H Thompson, MD DPhil; Gary A Wittert, MBBch MD FRACP; Grant Brinkworth, PhD
Presenter: Pennie J Taylor, PhD(c)
12:00pm T-P-3428-DT 12-Month Weight and Hba1c Outcomes by Insulin Status From the COMRADE Randomized Trial
Authors: Lesley D Lutes, PhD; Doyle M Cummings, PharmD; Kerry Littlewood, PhD; Stefanie Ciszweski, MA; Shivajirao P Patil, MD; Bertha Hambidge, MD; Chelsey Solar, MA; Peggy Gatlin; Marissa Carraway, PhD
Presenter: Lesley D Lutes, PhD
12:00pm T-P-3429 Effect of Setmelanotide (MC4R Agonist) on Obesity and Hunger in Individuals With Alström Syndrome
Authors: Joan C Han, MD; Webb A Smith, PhD; Elvin T Burton, PhD; Vijaya M Joshi, MD; Ali M Onder, MD; Teresa S Wright, MD; Michelle Hylan, BA; Cathy J Folster; Fred T Fiedorek, MD
Presenter: Joan C Han, MD
12:00pm T-P-3430 Establishing Protocols for Weight Loss Medication Prescribing and Monitoring in VA Healthcare System
Authors: Maria Romanova; James C Wong, MPH RD; Amanda A Blake, MS RD
Presenter: Maria Romanova
12:00pm T-P-3431 Naltrexone for Antipsychotic Induced Weight Gain: A Double-blind Randomized Placebo-controlled Trial
Authors: Cenk Tek, MD; Suat Kucukgoncu, MD; Sinan Guloksuz, MD PhD; Aniyizhai Annamalai, MD; Erin Sullivan, BA; Stephanie S O'Malley, PhD; Carlos M Grilo, PhD FTOS; Caroline Apovian, MD FACP FTOS DABOM
Presenter: Cenk Tek, MD
12:00pm T-P-3432 Nutrient Absorption Decreases With Both Calorie Restriction and Oral Vancomycin
Authors: Alessio Basolo, MD
Presenter: Alessio Basolo, MD
12:00pm T-P-3433 Metformin Improves CD8+ Memory T Lymphocyte Function in Obese Influenza Vaccinated Adults
Authors: Omar A Rezk, MSPH; William Green, MSPH; Melinda Beck, PhD
Presenter: Omar A Rezk, MSPH
12:00pm T-P-3434 Relationship Between Weight Loss Extent and Blood Pressure in Naltrexone/Bupropion Treated Patients
Authors: Amy Halseth, PhD; Lisette Acevedo, PhD MBA; Pete Flynn
Presenter: Amy Halseth, PhD
12:00pm T-P-3435 Efficacy/safety of Liraglutide 3.0 mg in Adults with Obesity/Overweight: BMI <50 kg/m² vs ≥50 kg/m²
Authors: Domenica M Rubino, MD; Ian D Caterson; Luc F Van Gaal, MD PhD; Frank L Greenway, MD; Meena Bhatta, MD; Michael T Lund, MD PhD; Niels Zeuthen; John Wilding, DM FRCP
Presenter: Domenica M Rubino, MD
12:00pm T-P-3436 Effect of Renal Impairment on the Pharmacokinetics of Naltrexone/Bupropion in a Single-Dose Study
Authors: Lisette Acevedo, PhD MBA; Amy Halseth, PhD; Pete Flynn
Presenter: Lisette Acevedo, PhD MBA
12:00pm T-P-3437 Very Low Calorie Diet Followed by Phentermine for Maintenance
Authors: Judy F Loper, PhD RDN FTOS; J. Thomas Broyles, MD; Robert May, MD; Edward J Baltes, MD
Presenter: Judy F Loper, PhD RDN FTOS
12:00pm T-P-3438 Single-Dose Pharmacokinetics of Naltrexone/Bupropion in Adolescents With Obesity
Authors: Aaron S Kelly, PhD; Lisette Acevedo, PhD MBA; Pete Flynn; Amy Halseth, PhD
Presenter: Aaron S Kelly, PhD
12:00pm T-P-3439 Real-world Medication Persistence and Dosing With Liraglutide 3.0 mg for Weight Management in Canada
Authors: Sean Wharton, MD FRCPC PharmD; Aiden Liu; Arash Pakseresht, MD; Emil Nørtoft, MSc; Christiane L Haase, MSc PhD; Johanna Mancini, BSc MSc PhD; Sarah Power; Sarah J VanderLelie, BASc; Rebecca AG Christensen, BASc MSc
Presenter: Sean Wharton, MD FRCPC PharmD
12:00pm T-P-3440 The Novel MetAP2 Inhibitor, ZGN-1258, Reduces Body Weight and Food Intake in Mouse Models of Obesity
Authors: Micaella P Fagan, PhD; Bryan Burkey, PhD; Douglas Lazarus, PhD; Frank Hsieh, PhD; Margaret A Wyman, BS; Thomas E Hughes, PhD; James Vath
Presenter: Micaella P Fagan, PhD
12:00pm T-P-3441 ZGN-1258: A Novel Potent MetAP2 Inhibitor With Reduced Risk of Coagulopathy
Authors: Micaella P Fagan, PhD; Bryan Burkey, PhD; Douglas Lazarus, PhD; Niel C Hoglen, PhD; Philip Inskeep, PhD; Margaret A Wyman, BS; Thomas E Hughes, PhD; James Vath
Presenter: Micaella P Fagan, PhD